Health Decisions Receives Safe Harbor Certification
Health Decisions
announced that it received Safe Harbor Certification effective February 15, 2011.
The Safe Harbor designation recognizes Health Decisions meets or exceeds directives of the European Union for data privacy and protection. The Safe Harbor framework was created by the US Department of Commerce in consultation with the Europe Commission's Directive on Data Protection to bridge differences in countries' privacy approaches and provide a streamlined means for US. organizations to comply with data protection laws.
"Health Decisions has always been committed to protecting the confidentiality and privacy of our customer’s data. This certification affirms that commitment," said Health Decisions Chief Operating Officer, Alicia Paladin. "We are pleased to be part of a limited group of organizations to be awarded this designation."
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
